ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Low-Carb diet help fight endometrial cancer?
Disease control CompletedThis study looks at whether a ketogenic diet—a very low-carbohydrate diet that forces the body to burn fat for energy—is safe and tolerable for overweight or obese women with newly diagnosed endometrial cancer before they have surgery. Nineteen participants will either follow the…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a third chemo drug tame advanced endometrial cancer?
Disease control CompletedThis study looked at whether adding a drug called epirubicin to the standard two-drug chemotherapy (paclitaxel and carboplatin) helps people with advanced endometrial cancer. Sixty patients were enrolled to see if the three-drug combo is better at controlling the disease before s…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug cocktail shows promise for Tough-to-Treat uterine cancer
Disease control CompletedThis phase 2 trial tested a combination of three drugs—rucaparib, bevacizumab, and atezolizumab—in 30 people with recurrent or progressive endometrial cancer that had not responded to prior treatments. The goal was to see if the combination could shrink tumors or slow the cancer'…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug duo shows promise against tough uterine cancer
Disease control CompletedThis phase 3 study tested whether combining the immunotherapy pembrolizumab with the targeted therapy lenvatinib works better than standard chemotherapy for women with advanced or recurrent endometrial cancer. Over 800 participants received either the drug combo or chemo. The goa…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new immunotherapy drug, ezabenlimab, combined with other cancer medicines in 211 adults with advanced solid tumors that had spread. The goal was to see if the tumors shrank or disappeared. Participants received different drug combinations, and doctors monitore…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy shows promise against tough uterine cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and lenvatinib, against standard chemotherapy for women with advanced or recurrent endometrial cancer. The goal was to see if the combo could slow cancer growth or improve survival better than chemo. The trial enrolled 1…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
How far should surgeons go? study tests lymph node removal in uterine cancer
Knowledge-focused CompletedThis study looked at 150 women with intermediate- or high-risk endometrial cancer who had surgery to remove the uterus and nearby lymph nodes. Researchers compared removing lymph nodes up to a higher level (near the kidney) versus a lower level (near the pelvis) to see which appr…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Ahmed Aouf • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Scientists probe muscle mysteries in cancer weight loss
Knowledge-focused CompletedThis completed study looked at how muscle energy use differs in women with ovarian or endometrial cancer who are losing weight, depending on their body mass index (BMI). Researchers took blood samples, muscle biopsies, and fat tissue from 70 women during surgery. The goal was to …
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Universal DNA screening in endometrial cancer reveals hidden genetic risks
Knowledge-focused CompletedThis study tested over 1,000 women with endometrial cancer for DNA repair problems that can be inherited (Lynch syndrome). By analyzing tumor DNA, researchers aimed to personalize cancer treatment and identify family members who might also be at risk. The goal was to improve care…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC